logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 12564626 B1

PDFFull Text
Date of Patent:
Mar. 03, 2026

Filed:

Dec. 20, 2019

Serum free intracellular pathogen vaccine

Applicant:

Intervet Inc., Madison, NJ (US);

Inventors:

Joseph Koumans, Wageningen, NL;

Petter Frost, Radal, NO;

Maria Forlenza, Wageningen, NL;

Assignee:

Intervet Inc., Rahway, NJ (US);

Attorney:

Susanna C. Benn

Primary Examiner:

Bao Q Li

Int. Cl.
CPC ...
A61K 39/205 (2006.01); A23K 10/16 (2016.01); A23K 10/18 (2016.01); A23K 10/24 (2016.01); A23K 20/147 (2016.01); A23K 50/80 (2016.01); A61K 35/16 (2015.01); A61K 39/002 (2006.01); A61K 39/005 (2006.01); A61K 39/02 (2006.01); A61K 39/12 (2006.01); A61K 39/145 (2006.01); A61P 31/12 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 39/205 (2013.01); A23K 10/16 (2016.05); A23K 10/18 (2016.05); A23K 10/24 (2016.05); A23K 20/147 (2016.05); A23K 50/80 (2016.05); A61K 35/16 (2013.01); A61K 39/002 (2013.01); A61K 39/005 (2013.01); A61K 39/0208 (2013.01); A61K 39/0233 (2013.01); A61K 39/12 (2013.01); A61K 39/145 (2013.01); A61P 31/12 (2018.01); A61K 2039/552 (2013.01); A61K 2039/70 (2013.01);
Abstract

A vaccine composition comprising a virus antigen wherein the composition comprises less than 5% serum, wherein the virus antigen is a whole virus or derived from a whole virus, the vaccine composition reduces, prevents or avoids cross-stitch spinal deformity in the treated animal. Said vaccine composition for use in a method of treating a disease caused by the intracellular pathogen in an animal and reducing, preventing or avoiding cross-stitch spinal deformity in the treated animal. In cross-stitch vertebra the intervertebral space is completely collapsed. A vaccine composition for use as defined above wherein the animal is a fish. In an embodiment the pathogen is salmon alpha virus (SAV).

Find Patent Forward Citations

Koumans, Joseph. (2026). Serum free intracellular pathogen vaccine (U.S. Patent No. 12564626). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/12564626

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…